OFAC Compliance Counsel for Medical Translation Services in Iran
Attempting to handle medical translation work from Iran sanctions 2026 without proper OFAC authorization exposes individuals and companies to civil penalties reaching millions of dollars. Medicine itself benefits from a humanitarian carve-out under U.S. sanctions law – but services, including translation, occupy a legally distinct and far less forgiving position. Before signing any contract with an Iranian counterparty, the regulatory picture under 31 CFR Part 560 must be understood in full.
Understanding US Sanctions on Medical Services in Iran
The Iranian Transactions and Sanctions Regulations (ITSR), codified at 31 CFR Part 560, form the primary legal framework governing U.S. persons’ dealings with Iran. As a general rule, OFAC prohibits the exportation, re-exportation, sale, or supply of services – directly or indirectly – to Iran or the Government of Iran. Healthcare occupies a narrow special status, but that status attaches to goods, not to every ancillary activity surrounding those goods.
The distinction is not academic. A pharmaceutical company shipping FDA-approved drugs to Iran under the appropriate authorization operates legally. A U.S.-based translator providing document services to an Iranian hospital under a direct contract may not – regardless of how medically necessary the underlying documents are.
| Category | OFAC Status 2026 |
| Medical Devices | Permitted under specific conditions (31 CFR § 560.530) |
| Pharmaceuticals | Generally authorized via General License (31 CFR § 560.530) |
| Healthcare Services | Restricted; specific license typically required |
| Medical Translation | Gray zone; depends on transaction structure |
The full scope of OFAC Iran sanctions programs – including the rules governing services – is summarized by legal practitioners who regularly work with Treasury on these issues.
Does Medical Translation Fall Under the OFAC Humanitarian Exemption?
The OFAC Iran humanitarian exemption medical carve-out under 31 CFR § 560.530 authorizes U.S. persons to export or re-export medicine and medical devices to Iran. The plain text of the regulation targets goods – not services rendered to Iranian entities in the course of treating patients or administering healthcare programs. Translating a pharmaceutical package insert for export alongside an authorized drug shipment sits in a different legal position than translating a patient’s clinical records for an Iranian hospital.
The practical line: if the translation is a component of a lawful goods export, it may qualify as incidental. If the translation is a standalone service delivered to an Iranian person or entity, it almost certainly does not.
OFAC General License for Medicine and Services
The OFAC general license medicine Iran provision under 31 CFR § 560.530 authorizes the export of medicine, medical devices, and certain agricultural commodities. Critically, it extends to services that are “ordinarily incident to” those authorized exports – such as shipping documentation, product labeling translation bundled with the export transaction, or regulatory submission materials required by Iranian authorities to accept the goods.
Translation work falling within that “incidental to” boundary is defensible. However, OFAC has not issued a blanket general license for Iran medical translation OFAC license purposes. The scope of what qualifies as incidental is fact-specific and has generated enforcement uncertainty. General license details for Iran sanctions explain how these authorizations are structured and where their edges lie.
Note: the regulation’s text specifically addresses training rather than translation — the incidental-services argument for translation work is an interpretive position based on the regulation’s purpose, not an explicitly enumerated category.
When Do You Need a Specific OFAC License?
The general license framework breaks down when the translation relationship is independent of any authorized goods transaction. In those scenarios, an OFAC license for medical translation Iran – a specific license issued by OFAC’s Licensing Division – becomes the required authorization. Operating without one violates the ITSR regardless of the humanitarian nature of the work.
Situations that typically require a specific license:
- Providing ongoing translation services directly to an Iranian government-operated hospital or clinic under a services contract;
- Translating clinical trial data or research materials for an Iranian institution without a connected goods export;
- Contracting with any person or entity appearing on OFAC’s Specially Designated Nationals (SDN) list, even for ostensibly benign medical work;
- Supplying Iran-based entities with translated training materials for medical equipment under a services agreement separate from the original equipment sale.
Understanding the SDN list removal process and how SDN designations affect service transactions is a prerequisite for any compliance review.
How to Ensure Iran Healthcare Sanctions Compliance
Iran healthcare sanctions compliance is not a checkbox exercise. Working without a clear legal opinion on the transaction structure creates liability exposure that persists even when the intent behind the work is purely humanitarian. OFAC enforcement actions do not require proof of intent for civil violations – strict liability applies in many circumstances under 31 CFR Part 560.
Before initiating any translation engagement involving Iranian counterparties, a structured screening process is obligatory.
Compliance checklist:
- Check the SDN list – Screen the counterparty, any intermediary, and the ultimate beneficiary against OFAC’s SDN list using the official search tool at sanctions.OFAC.treas.gov. Any match terminates the transaction.
- Determine whether the work is “incidental” to exempt goods – Analyze whether the translation is part of an authorized medical goods export under 31 CFR § 560.530 or a freestanding service. Document that analysis in writing.
- Apply for a specific license if no general license applies – Submit a specific license application to OFAC’s Licensing Division at U.S. Treasury before commencing work. Applications must include a full transaction description, parties involved, and legal basis.
Comprehensive OFAC compliance guidance covers the due diligence procedures that organizations operating in sanctioned territories are expected to follow.
Foreign translation companies — even those with no U.S. nexus — may face Iran secondary sanctions if they provide services to Iranian entities on the SDN list.
Why Consult an Iran Sanctions Lawyer for Medical Work?
Civil monetary penalties for OFAC violations in 2026 reach up to $356,579 per transaction or twice the value of the transaction – whichever is greater. Criminal penalties under IEEPA for willful violations carry fines of up to $1,000,000 and imprisonment. An Iran healthcare sanctions compliance lawyer provides the legal analysis that separates defensible transactions from those carrying enforcement risk. The cost of a legal opinion is negligible relative to the penalties attached to a mischaracterized services agreement.
An attorney experienced with Iran medical work sanctions lawyer engagements can assess whether the general license covers the specific work, structure the transaction to fall within its scope where possible, or prepare and submit an OFAC license application for specific authorization when required. The application process involves detailed factual submissions and legal argument – not a form filing.
Case example: A U.S. medical documentation company sought to provide translation services for pharmaceutical shipments destined for a private Iranian hospital. Counsel, attorney Dmytro Konovalenko, reviewed the transaction structure and determined the translation work qualified as incidental to an authorized goods export under 31 CFR § 560.530 – but only because the services agreement was restructured to attach directly to the export transaction rather than to the hospital as the primary counterparty. The company proceeded without a specific license, with a documented legal basis on file. Had the contract been executed as originally drafted, a specific license application would have been required, and enforcement exposure would have existed in the interim.
Iran-related secondary sanctions present an additional layer of risk for non-U.S. persons involved in these transactions — a dimension that counsel can address in the same engagement. This risk is particularly acute because the regulatory boundary between permitted medical goods exports and prohibited service transactions is not self-evident.
Consequently, even specialized support activities like translation engagements connected to Iran require a documented compliance analysis before work begins — not after. Contact an OFAC sanctions attorney to evaluate the specific transaction structure and determine whether existing general licenses apply or a specific license application is required.
FAQ
Is medical translation for Iran covered by the general humanitarian license?
Not automatically. The general license under 31 CFR § 560.530 covers medicine and medical devices as goods — translation is only covered when it’s genuinely incidental to an authorized export (e.g., translating a package insert bundled with an approved drug shipment). A standalone translation contract with an Iranian hospital or clinic — even for clearly humanitarian purposes — typically falls outside the general license and needs its own specific authorization.
What happens if I already signed a translation contract with an Iranian counterparty before checking this?
Stop work and get the transaction reviewed before continuing. OFAC applies strict liability to civil violations under 31 CFR Part 560 — good intent or humanitarian purpose doesn’t excuse an unlicensed service transaction. Depending on how the contract is structured, counsel may be able to restructure it to fall within the “incidental to” exemption, or file a specific license application to bring ongoing work into compliance.
Do foreign (non-U.S.) translation companies need to worry about Iran sanctions too?
Yes, if the client or intermediary is an SDN-listed entity. Foreign companies with no U.S. nexus can still face Iran secondary sanctions for providing services to sanctioned Iranian parties. Screening the counterparty against the SDN list before signing is necessary regardless of where the translation company is based.
